Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Short term Debt (2018 - 2019)

Sunshine Biopharma's Short term Debt history spans 2 years, with the latest figure at $27541.0 for Q3 2019.

  • For Q3 2019, Short term Debt changed N/A year-over-year to $27541.0; the TTM value through Sep 2019 reached $27541.0, changed N/A, while the annual FY2018 figure was $20871.0, N/A changed from the prior year.
  • Short term Debt reached $27541.0 in Q3 2019 per SBFM's latest filing, down from $27869.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $59558.0 in Q1 2019 to a low of $20871.0 in Q4 2018.